|
KDSR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.497400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.705800E-01 |
| Normal-vs-Stage2 |
5.010800E-01 |
| Normal-vs-Stage3 |
9.279600E-01 |
| Normal-vs-Stage4 |
5.897000E-01 |
| Stage1-vs-Stage2 |
5.089000E-01 |
| Stage1-vs-Stage3 |
9.901000E-01 |
| Stage1-vs-Stage4 |
6.211600E-01 |
| Stage2-vs-Stage3 |
5.941400E-01 |
| Stage2-vs-Stage4 |
3.527400E-01 |
| Stage3-vs-Stage4 |
7.157600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.484400E-01 |
| Normal-vs-AfricanAmerican |
4.853200E-01 |
| Normal-vs-Asian |
3.805400E-01 |
| Caucasian-vs-AfricanAmerican |
3.953600E-01 |
| Caucasian-vs-Asian |
3.640400E-01 |
| AfricanAmerican-vs-Asian |
2.223800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.440800E-01 |
| Normal-vs-Female |
4.567900E-02 |
| Male-vs-Female |
5.981800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.352200E-01 |
| Normal-vs-Extreme_Weight |
3.405400E-01 |
| Normal-vs-Obese |
4.381800E-01 |
| Normal-vs-Extreme_Obese |
7.350000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.011600E-01 |
| Normal_Weight-vs-Obese |
4.833400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.570800E-01 |
| Extreme_Weight-vs-Obese |
1.357190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.404400E-01 |
| Obese-vs-Extreme_Obese |
5.072000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.978400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.477630E-01 |
| Normal-vs-Age(61-80Yrs) |
3.702400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.561200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.615000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.897800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.456000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.315800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.693000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.813000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.492600E-01 |
| Normal-VS-Type2 PRCC |
5.185900E-02 |
| Normal-VS-KIRP CIMP |
4.073700E-02 |
| Normal-VS-Unclassified PRCC |
6.345000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.155600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.056300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.962200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.740780E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.196200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.666980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.382600E-01 |
| Normal-vs-N1 |
1.850010E-01 |
| Normal-vs-N2 |
5.861200E-01 |
| N0-vs-N1 |
7.415000E-01 |
| N0-vs-N2 |
2.946800E-01 |
| N1-vs-N2 |
1.677420E-01 |
|
|
